Z6尊龙

	SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. (09989)

? Cover ? Important ? Expected Timetable ? Contents ? Summary ? Definitions ? Glossary of Technical Terms ? Forward-looking Statements ? Risk Factors ? Waivers and Consents from Strict Compliance with the Hong Kong Listing Rules ? Information about this Prospectus and the Global Offering ? Directors, Supervisors and Parties Involved in the Global Offering ? Corporate Information ? Industry Overview ? Regulatory Environment ? History, Development and Corporate Structure ? Business ? Relationship with the Controlling Shareholders ? Connected Transaction ? Directors, Supervisors and Senior Management ? Share Capital ? Substantial Shareholders ? Cornerstone Investors ? Financial Information ? Future Plans and Use of Proceeds ? Underwriting ? Structure of the Global Offering ? How to Apply for the Hong Kong Offer Shares ? Appendix I - Accountants' Report ? Appendix IA - Report on Review of Interim Condensed Consolidated Financial Information for the Three Months Ended March 31, 2020 ? Appendix II - Unaudited Pro Forma Financial Information ? Appendix III - Taxation and Foreign Exchange ? Appendix IV - Summary of Principal Legal and Regulatory Provisions ? Appendix V - Summary of Articles of Association ? Appendix VI - Statutory and General Information ? Appendix VII - Documents Delivered to the Registrar of Companies in Hong Kong and Available for Inspection ? Back Cover